CLINICAL_TRIALS
withdrawal
· 2025-05-04
Clinical Trial Update: AMG 714 Expanded Access Program
Summary
Amgen's AMG 714 Expanded Access Program for celiac disease is no longer available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Celiac Disease | Status: NO_LONGER_AVAILABLE